Avalo Therapeutics Inc (NAS:AVTX)
$ 9.55 -0.44 (-4.4%) Market Cap: 99.93 Mil Enterprise Value: 18.62 Mil PE Ratio: 0 PB Ratio: 4.39 GF Score: 47/100

Avalo Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 20, 2023 / 02:30PM GMT
Release Date Price: $10.32 (-6.52%)
Operator

Thanks for standing by, and welcome to the 2023 annual meeting of stockholders of Avalo Therapeutics, Inc. I would now like to welcome Garry Neil to begin the call. Garry, over to you.

Garry Neil Avalo Therapeutics Inc;Chairman;CEO

&

Thanks, Monty. Good morning. I'd like to officially call the meeting to order and welcome you all to the reconvened 2023 annual meeting of stockholders of Avalo Therapeutics Incorporated. I am Garry Neil, Chief Executive Officer and Chairman of the Board of Directors of the company.

This meeting is being held virtually in an effort to make the meeting as accessible as possible to our stockholders. We appreciate your participation today.

Before proceeding to the business of the meeting, I'd like to introduce you to the members of the Board of Directors who are in attendance today through remote access: Dr. June Almenoff, Mitchell Chan, Dr. Gilla Kaplan, and Dr. Magnus Persson.

In addition to members of our Board, we also have the following representatives of the management team

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot